Enable JavaScript to ensure website accessibility
Precipio’s HemeScreen® Selected as 2022 Best New Product

HemeScreen® Technology and Product Line were recognized by Fisher Healthcare during recent National Sales Meeting [...]

Precipio Signs Another Major HemeScreen™ Customer

Customer’s initial annual revenue expected at $650K, $2.0M revenue at full capacity NEW HAVEN, CT, [...]

Precipio Signs Additional Major HemeScreen™ Customer

Customer to begin gradually onboarding panels in Q1-2023, potential $1.2M revenue at full capacity NEW [...]

Precipio Presents Poster on HemeScreen® Study at Association of Molecular Pathology (AMP) 2022 Annual Conference

Poster presents findings of a study of ~1000 patient samples demonstrating superior accuracy for HemeScreen™ [...]

Precipio Announces Third Quarter Shareholder Update Call

Conference Call to be held on Monday, November 14th, 2022 at 5:00 PM ET NEW [...]

Precipio Signs Agreement with Another Major US Healthcare Distributor for HemeScreen™

Adding customer segment exceeding $100M in market potential NEW HAVEN, CT, Globenewswire – (September 15th, [...]

Sharon Robins Joins Precipio’s Products Division As Senior Director Of Laboratory & Hospital Sales

Precipio continues to build strong team in anticipation of substantial growth in the next 12 [...]

Precipio Launches New 1-Step Technology For All HemeScreen Assays

New technology enables same day test results by eliminating extra confirmation step NEW HAVEN, CT, [...]

Toni-Ann Mills Joins Precipio’s Products Division To Lead Channel Partner Training, Learning & Development

Precipio prepares to launch a nationwide HemeScreen sales effort of 250+ sales reps from AmerisourceBergen, [...]

Precipio Announces Second Quarter Shareholder Update Call

Conference Call to be held on Monday, August 15th, 2022 at 5:00 PM EST NEW [...]